• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有快速进展性肾小球肾炎和皮肤毛霉病的儿科患者的管理:病例报告

Management of a pediatric patient with rapidly progressive glomerulonephritis and cutaneous mucormycosis: a case report.

作者信息

Jia Lili, Shi Kaili, Sun Xiaoyi, Xu Feng, Sun Tao, Gao Chunlin

机构信息

Department of Pediatrics, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.

Department of Pediatrics, Jinling School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

Front Pediatr. 2025 May 8;13:1484145. doi: 10.3389/fped.2025.1484145. eCollection 2025.

DOI:10.3389/fped.2025.1484145
PMID:40406353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12094951/
Abstract

Mucormycosis is a highly invasive and rare opportunistic infection caused by mucor fungi, characterized by challenging diagnosis and rapid disease progression. It predominantly affects patients with compromised immune systems due to various reasons, such as kidney failure, long-term use of antibiotics or corticosteroids. We recently successfully treated a pediatric patient with rapidly progressive glomerulonephritis accompanied by severe cutaneous mucormycosis. To our knowledge, this is the first reported case of rapidly progressive glomerulonephritis nephritis accompanied by dermatophytosis in a pediatric patient. In this case, we share our management experience, including special nursing experience. Cutaneous mucormycosis progresses quickly and is difficult to diagnose and treat, especially in children with compromised immune function, warranting high vigilance from clinicians and nursing staff. Early diagnosis and targeted treatment are crucial for improving the prognosis of patients. Therefore, once there is a suspicion of a mucormycosis infection, we recommend the early application of various testing methods such as fungal culture, skin biopsy and genetic testing in order to to promptly confirm the diagnosis.

摘要

毛霉病是一种由毛霉真菌引起的高度侵袭性且罕见的机会性感染,其特点是诊断具有挑战性且疾病进展迅速。它主要影响因各种原因导致免疫系统受损的患者,如肾衰竭、长期使用抗生素或皮质类固醇。我们最近成功治疗了一名患有快速进展性肾小球肾炎并伴有严重皮肤毛霉病的儿科患者。据我们所知,这是首例报道的儿科患者快速进展性肾小球肾炎伴有皮肤癣菌病的病例。在此病例中,我们分享我们的治疗经验,包括特殊护理经验。皮肤毛霉病进展迅速,难以诊断和治疗,尤其是在免疫功能受损的儿童中,需要临床医生和护理人员高度警惕。早期诊断和针对性治疗对于改善患者预后至关重要。因此,一旦怀疑有毛霉病感染,我们建议尽早应用各种检测方法,如真菌培养、皮肤活检和基因检测,以便及时确诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32cc/12094951/4ffa7fc2b060/fped-13-1484145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32cc/12094951/39480be9a104/fped-13-1484145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32cc/12094951/4ffa7fc2b060/fped-13-1484145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32cc/12094951/39480be9a104/fped-13-1484145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32cc/12094951/4ffa7fc2b060/fped-13-1484145-g002.jpg

相似文献

1
Management of a pediatric patient with rapidly progressive glomerulonephritis and cutaneous mucormycosis: a case report.一名患有快速进展性肾小球肾炎和皮肤毛霉病的儿科患者的管理:病例报告
Front Pediatr. 2025 May 8;13:1484145. doi: 10.3389/fped.2025.1484145. eCollection 2025.
2
A Case of Post-COVID Mucormycosis in a Diabetic Patient in Pakistan.巴基斯坦一名糖尿病患者的新冠后毛霉菌病病例
Cureus. 2024 Nov 30;16(11):e74852. doi: 10.7759/cureus.74852. eCollection 2024 Nov.
3
A Rare Case of Maxillary Mucormycosis in a Child With Juvenile Diabetes Mellitus.一名患有青少年糖尿病的儿童上颌毛霉菌病罕见病例。
Cureus. 2024 Jun 4;16(6):e61666. doi: 10.7759/cureus.61666. eCollection 2024 Jun.
4
[Cutaneous mucormycosis caused by Rhizopus microsporus].由微小根霉引起的皮肤毛霉病
Ann Dermatol Venereol. 2014 Mar;141(3):201-5. doi: 10.1016/j.annder.2013.10.044. Epub 2013 Dec 11.
5
A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia.宏基因组学下一代测序用于早期检测中枢神经系统毛霉菌病并成功救治复发性慢性淋巴细胞白血病患者的病例报告
Ann Transl Med. 2022 Jun;10(12):722. doi: 10.21037/atm-22-2533.
6
Vesicoureteral Reflux膀胱输尿管反流
7
Detection of antibody-coated Mucor in skin biopsy by direct immunofluorescence.直接免疫荧光法检测皮肤活检中的抗体包被毛霉。
J Cutan Pathol. 2023 Jul;50(7):637-641. doi: 10.1111/cup.14435. Epub 2023 Apr 16.
8
A rare presentation of rhino-orbital-cutaneous mucormycosis in an immunocompetent patient: a case report.免疫功能正常患者罕见的鼻眶皮脑毛霉病表现:一例病例报告。
Pan Afr Med J. 2024 May 15;48:13. doi: 10.11604/pamj.2024.48.13.43454. eCollection 2024.
9
Primary cutaneous mucormycosis caused by Mucor irregularis in an elderly person.一名老年人由不规则毛霉引起的原发性皮肤毛霉病。
J Dermatol. 2015 Feb;42(2):210-4. doi: 10.1111/1346-8138.12736. Epub 2014 Dec 16.
10
A Case of Microscopic Polyangiitis Complicated by Mucormycosis: A Dangerous Balancing Act.一例合并毛霉病的显微镜下多血管炎:一场危险的平衡行为。
Cureus. 2023 Feb 13;15(2):e34941. doi: 10.7759/cureus.34941. eCollection 2023 Feb.

本文引用的文献

1
COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.COVID-19 相关霉菌感染:COVID-19 相关肺曲霉病和毛霉菌病的综述。
J Microbiol Immunol Infect. 2023 Jun;56(3):442-454. doi: 10.1016/j.jmii.2022.12.004. Epub 2022 Dec 15.
2
Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents.毛霉菌病:真菌感染的隐藏谜团,可能的诊断、治疗和新治疗药物的研发。
Eur J Med Chem. 2023 Jan 15;246:115010. doi: 10.1016/j.ejmech.2022.115010. Epub 2022 Dec 10.
3
Rapidly progressive glomerulonephritis in children.
儿童快速进展性肾小球肾炎
Pak J Med Sci. 2022 Jan;38(2):417-425. doi: 10.12669/pjms.38.ICON-2022.5774.
4
Mucormycosis in Mainland China: A Systematic Review of Case Reports.中国大陆的毛霉菌病:病例报告的系统评价。
Mycopathologia. 2022 Feb;187(1):1-14. doi: 10.1007/s11046-021-00607-4. Epub 2021 Dec 2.
5
Mucormycosis treatment: Recommendations, latest advances, and perspectives.毛霉病治疗:推荐意见、最新进展和展望。
J Mycol Med. 2020 Sep;30(3):101007. doi: 10.1016/j.mycmed.2020.101007. Epub 2020 Jun 20.
6
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.全球毛霉病诊断和管理指南:欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
7
Mucormycosis in Children: Review and Recommendations for Management.儿童毛霉菌病:治疗管理的综述和建议。
J Pediatric Infect Dis Soc. 2018 May 15;7(2):159-164. doi: 10.1093/jpids/pix107.
8
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.高剂量(10毫克/千克/天)脂质体两性霉素B(L-AMB)用于毛霉菌病初始治疗的前瞻性试点研究。
J Antimicrob Chemother. 2015 Nov;70(11):3116-23. doi: 10.1093/jac/dkv236. Epub 2015 Aug 27.
9
Why is mucormycosis more difficult to cure than more common mycoses?为什么毛霉菌病比更常见的真菌感染更难治愈?
Clin Microbiol Infect. 2014 Jun;20 Suppl 6:74-81. doi: 10.1111/1469-0691.12466. Epub 2014 Jan 28.
10
Epidemiology and clinical manifestations of mucormycosis.毛霉病的流行病学和临床表现。
Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34. doi: 10.1093/cid/cir866.